Rush Presbyterian - St. Lukes Medical Center — Chicago, Illinois

Rush Presbyterian - St. Lukes Medical Center is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Rush Presbyterian - St. Lukes Medical Center has participated in 5 clinical trials.

Therapeutic areas: Graft-versus-Host Disease, Primary Immunodeficiency Diseases (PID), Immune Thrombocytopenic Purpura (ITP).

Sponsors: Mallinckrodt, Baxalta now part of Shire, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush Presbyterian - St. Lukes Medical Center?

Rush Presbyterian - St. Lukes Medical Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush Presbyterian - St. Lukes Medical Center conducted?

Rush Presbyterian - St. Lukes Medical Center has 5 clinical trials on record. Their work covers Graft-versus-Host Disease, Primary Immunodeficiency Diseases (PID), Immune Thrombocytopenic Purpura (ITP).

Is Rush Presbyterian - St. Lukes Medical Center accredited by Crixeo Health?

Yes — Rush Presbyterian - St. Lukes Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rush Presbyterian - St. Lukes Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.